Phillies Closer José Alvarado Suspended for 80 Games for Positive Drug Test
- Philadelphia Phillies closer José Alvarado received an 80-game suspension on Sunday for testing positive for performance-enhancing drugs.
- The suspension followed a positive test for exogenous testosterone detected about 10 days earlier, which the team attributes to a weight-loss medication.
- Alvarado, a Venezuelan left-hander with a 2.70 ERA and seven saves this season, accepted the suspension without appeal, leaving the Phillies to adjust their bullpen roles accordingly.
- Phillies president Dave Dombrowski called the situation "disappointing for sure" but said, "We've got to move on," as Jose Ruiz replaced Alvarado on the active roster.
- The suspension sidelines Alvarado through at least August 19 and excludes him from postseason eligibility, prompting the Phillies to consider trades or internal bullpen adjustments.
79 Articles
79 Articles
Phillies reliever José Alvarado is suspended 80 games for PED use
PHILADELPHIA — Phillies reliever José Alvarado has been suspended without pay for 80 games after testing positive for exogenous testosterone, a performance-enhancing drug, MLB announced Sunday. As a result, Alvarado will not be eligible for the postseason this year.
Philadelphia Phillies closer José Alvarado suspended for 80 games for positive drug test
PHILADELPHIA — Philadelphia Phillies closer José Alvarado was suspended for 80 games on Sunday following a positive test for external testosterone under Major League Baseball’s drug-testing program. Alvarado, among the hardest-throwing relievers, became the second player suspended this year under the big league testing program after Atlanta outfielder Jurickson Profar. Phillies president of baseball operations Dave Dombrowski said the positive t…

Phillies reliever Alvarado suspended for positive test
Philadelphia Phillies pitcher Jose Alvarado has been handed an 80-game suspension after testing positive for a banned performance-enhancing substance, Major League Baseball said Sunday.
Coverage Details
Bias Distribution
- 48% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage